Results 91 to 100 of about 10,207 (186)

Correlation Between Histological Grading and Ploidy Status in Oral Leukoplakia, Oral Submucous Fibrosis, and Oral Squamous Cell Carcinoma: A Flow Cytometric Analysis. [PDF]

J Pharm Bioallied Sci, 2020
Velidandla S, Manikya S, Gajjada N, Reddy S, Gogulamudi L, Mediconda S.   +5 more
europepmc   +1 more source

Oral Leukoplakia [PDF]

Journal of the Royal Society of Medicine, 1980
openaire   +2 more sources

Efficacy of Lycopene in the Management of Oral Leukoplakia – A Systematic Review

Journal of Indian Academy of Oral Medicine and Radiology
Background: Leukoplakia is majorly treated pharmacologically and surgically along with counselling of patients for complete stoppage of habit. In spite of multiple treatment modalities, complete remission of lesions has not been achieved till date. Hence,
Tapasya Karemore, Mukta Motwani, Pawan Motghare, Shiwani Dalal, Arati Panchbhai, Trushita Banubakode   +5 more
doaj   +1 more source

[Oral leukoplakia].

Medicina clinica, 1996
J I, Iriarte Ortabe, J, Caubet Biayna, H, Reychler   +2 more
  +8 more sources

Leukoplakia and Oral Cancer [PDF]

Proceedings of the Royal Society of Medicine, 1969
openaire   +2 more sources

Oral leukoplakia: Diagnosis and treatment

Journal of Oral Health and Oral Epidemiology, 2016
BACKGROUND AND AIM: Oral leukoplakia (OL) is a common premalignant lesion. The possible benefits of specific interventions in preventing a malignant transformation of OL are not well understood. This review assesses different invasive treatment techniques for OL and evaluate the optimal treatment possibilities.
Larsen, Marie Kjærgaard, Sørensen, Jens Ahm, Godballe, Christian, Thygesen, Torben   +3 more
openaire   +3 more sources

Comparative study on salivary IL- 8 and LDH among tobacco users without lesions, leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma. [PDF]

Bioinformation
Venkatesh S, K SG, Ganesan N.
europepmc   +1 more source

Serum iron, zinc and copper among Indian patients with leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma. [PDF]

Bioinformation
Kavle P, Dubey R, Sasank Tejaswee AS, Kaur G, Mondal A, D Patel V, Patel KJ, Vaghani AR.   +7 more
europepmc   +1 more source

Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis. [PDF]

Head Neck Pathol
Yasothkumar D, Ramani P, Jayaraman S, Ramalingam K, Tilakaratne WM.   +4 more
europepmc   +1 more source

Immune suppression, HLA-risk and potential future immune based targets of oral leukoplakia progression. [PDF]

Front Dent Med
Soni M, DeSantis B, Villa A, Kamoun M, Gates J.   +4 more
europepmc   +1 more source